Literature DB >> 25381357

Role and regulation of CD1d in normal and pathological B cells.

Mohammed S Chaudhry1, Anastasios Karadimitris2.   

Abstract

CD1d is a nonpolymorphic, MHC class I-like molecule that presents phospholipid and glycosphingolipid Ags to a subset of CD1d-restricted T cells called invariant NKT (iNKT) cells. This CD1d-iNKT cell axis regulates nearly all aspects of both the innate and adaptive immune responses. Expression of CD1d on B cells is suggestive of the ability of these cells to present Ag to, and form cognate interactions with, iNKT cells. In this article, we summarize key evidence regarding the role and regulation of CD1d in normal B cells and in humoral immunity. We then extend the discussion to B cell disorders, with emphasis on autoimmune disease, viral infection, and neoplastic transformation of B lineage cells, in which CD1d expression can be altered as a mechanism of immune evasion and can have both diagnostic and prognostic importance. Finally, we highlight current and future therapeutic strategies that aim to target the CD1d-iNKT cell axis in B cells.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25381357      PMCID: PMC4512253          DOI: 10.4049/jimmunol.1401805

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

Review 1.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 2.  Marginal zone B cells in lymphocyte activation and regulation.

Authors:  Thiago Lopes-Carvalho; Jeremy Foote; John F Kearney
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

3.  NK T cells provide lipid antigen-specific cognate help for B cells.

Authors:  Elizabeth A Leadbetter; Manfred Brigl; Petr Illarionov; Nadia Cohen; Megan C Luteran; Shiv Pillai; Gurdyal S Besra; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

4.  CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes.

Authors:  M Exley; J Garcia; S B Wilson; F Spada; D Gerdes; S M Tahir; K T Patton; R S Blumberg; S Porcelli; A Chott; S P Balk
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

5.  SAP expression in invariant NKT cells is required for cognate help to support B-cell responses.

Authors:  Cynthia Detre; Marton Keszei; Natividad Garrido-Mesa; Katalin Kis-Toth; Wilson Castro; Amma F Agyemang; Natacha Veerapen; Gurdyal S Besra; Michael C Carroll; George C Tsokos; Ninghai Wang; Elizabeth A Leadbetter; Cox Terhorst
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

Review 6.  The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Cancer Immunol Immunother       Date:  2014-01-03       Impact factor: 6.968

7.  The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.

Authors:  Ioannis Kotsianidis; Evangelia Nakou; Emmanouil Spanoudakis; Irene Bouchliou; Eleytherios Moustakidis; Paraskevi Miltiades; Chrisa M Vadikolia; Richard Szydlo; Anastasios Karadimitris; Costas Tsatalas
Journal:  Am J Clin Pathol       Date:  2011-09       Impact factor: 2.493

8.  Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma.

Authors:  Joshua Richter; Natalia Neparidze; Lin Zhang; Shiny Nair; Tamara Monesmith; Ranjini Sundaram; Fred Miesowicz; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  Blood       Date:  2012-10-24       Impact factor: 22.113

9.  PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells.

Authors:  Istvan Szatmari; Attila Pap; Ralph Rühl; Jiang-Xing Ma; Petr A Illarionov; Gurdyal S Besra; Eva Rajnavolgyi; Balazs Dezso; Laszlo Nagy
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

10.  CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.

Authors:  Grazia Galli; Sandra Nuti; Simona Tavarini; Luisa Galli-Stampino; Claudia De Lalla; Giulia Casorati; Paolo Dellabona; Sergio Abrignani
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  18 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

2.  Regulatory and IgE+ B Cells in Allergic Asthma.

Authors:  John Paul Oliveria; Rita Agayby; Gail M Gauvreau
Journal:  Methods Mol Biol       Date:  2021

3.  STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis.

Authors:  Abhirami K Iyer; Jianyun Liu; Richard M Gallo; Mark H Kaplan; Randy R Brutkiewicz
Journal:  Immunology       Date:  2015-09-21       Impact factor: 7.397

4.  Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features.

Authors:  Roeland Lameris; Renée C G de Bruin; Paul M P van Bergen En Henegouwen; Henk M Verheul; Sonja Zweegman; Tanja D de Gruijl; Hans J van der Vliet
Journal:  Immunology       Date:  2016-09       Impact factor: 7.397

Review 5.  Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective.

Authors:  Amrendra Kumar; Naveenchandra Suryadevara; Timothy M Hill; Jelena S Bezbradica; Luc Van Kaer; Sebastian Joyce
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 6.  Natural Killer T Cells in Cancer Immunotherapy.

Authors:  Shiny Nair; Madhav V Dhodapkar
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

Review 7.  Expansion and Sub-Classification of T Cell-Dependent Antibody Responses to Encompass the Role of Innate-Like T Cells in Antibody Responses.

Authors:  Chanho Park; Tae Jin Kim
Journal:  Immune Netw       Date:  2018-10-23       Impact factor: 6.303

Review 8.  Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy.

Authors:  Benjamin J Wolf; Jiyoung Elizabeth Choi; Mark A Exley
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

Review 9.  Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Authors:  Pui Yeng Lam; Michael D Nissen; Stephen R Mattarollo
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

10.  Low oxygen saturation during sleep reduces CD1D and RAB20 expressions that are reversed by CPAP therapy.

Authors:  Tamar Sofer; Ruitong Li; Roby Joehanes; Honghuang Lin; Adam C Gower; Heming Wang; Nuzulul Kurniansyah; Brian E Cade; Jiwon Lee; Stephanie Williams; Reena Mehra; Sanjay R Patel; Stuart F Quan; Yongmei Liu; Jerome I Rotter; Stephen S Rich; Avrum Spira; Daniel Levy; Sina A Gharib; Susan Redline; Daniel J Gottlieb
Journal:  EBioMedicine       Date:  2020-06-05       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.